# Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy

> **NCT05486897** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 315 (actual)

## Conditions studied

- Cerebral Amyloid Angiopathy
- Hypertensive Arteriopathy

## Interventions

- **OTHER:** None, pure observational study

## Key facts

- **NCT ID:** NCT05486897
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-05
- **Primary completion:** 2023-12-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486897, "Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05486897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
